Dental Biomaterials

Your 2 Minute Guide to the Global Dental Bone Graft Substitute Market

No comments
Your 2 Minute Guide to the Global Dental Bone Graft Substitute Market

2020 was an unusual year mainly due to the global COVID-19 pandemic, which caused a 27% decrease in the global dental bone graft substitute (DBGS) and other biomaterials market from 2019 to 2020. Following the closure of non-essential businesses in Q1 and much of Q2 2020, the dental implant and bone graft substitute markets began

Emma MatrickYour 2 Minute Guide to the Global Dental Bone Graft Substitute Market
read more

3 Questions about the U.S. Dental Implants and Bone Graft Substitutes Market You Need to Know the Answers To

No comments
3 Questions about the U.S. Dental Implants and Bone Graft Substitutes Market You Need to Know the Answers To

iData’s U.S. market report for dental bone graft substitutes and other biomaterials includes dental bone graft substitutes, dental growth factors, and dental barrier membranes. Dental bone graft substitutes (DBGS) represented the largest segment within the dental biomaterials market. Dental bone graft substitutes heavily rely on the dental implant market. There are corresponding trends between these

Emma Matrick3 Questions about the U.S. Dental Implants and Bone Graft Substitutes Market You Need to Know the Answers To
read more

LYNCH Biologics Relaunches GEM21S Dental Biomaterial

No comments
LYNCH Biologics Relaunches GEM21S Dental Biomaterial

Register to receive a free Dental Bone Graft Substitutes Market Analysis, Size, and Trends Report synopsis and brochure. Tennessee-based LYNCH Biologics is a biotechnology company that provides treatments for patients that are experiencing difficulties with healing from anything ranging from a foot ulcer to dental surgery. In an effort to expand their product portfolio, they

iData ResearchLYNCH Biologics Relaunches GEM21S Dental Biomaterial
read more

Biomaterial Could Promote Living Dental Pulp After Root Canal

No comments
Biomaterial Could Promote Living Dental Pulp After Root Canal

Register to receive a free US Market Report Suite for Dental Bone Graft Substitutes and Other Biomaterials report synopsis and brochure Scientists have reported the development of a peptide hydrogel biomaterial designed to promote the growth of new dental pulp and blood vessels following a root canal. Traditionally, a root canal procedure involves the removal of infected

iData ResearchBiomaterial Could Promote Living Dental Pulp After Root Canal
read more

Inventor of Bone Regrowing Dental Technology is Edison Awards Finalist

No comments
Inventor of Bone Regrowing Dental Technology is Edison Awards Finalist

Register to receive a free US Market Report Suite for Dental Bone Graft Substitutes and Other Biomaterials report synopsis and brochure On January 24th, it was announced that Dr. Amos Yahav, the founder of Augma Biomaterials, has earned a finalist spot at the 2019 Edison Awards. Dr. Yahav obtained his finalist position with the invention of Bond Apatite®,

iData ResearchInventor of Bone Regrowing Dental Technology is Edison Awards Finalist
read more

LYNCH Biologics Closes on Transaction to Purchase GEM 21S® Growth Factor Enhanced Matrix for Dental Bone Regeneration

No comments
LYNCH Biologics Closes on Transaction to Purchase GEM 21S® Growth Factor Enhanced Matrix for Dental Bone Regeneration

Register to receive a free US Market Report Suite for Dental Bone Graft Substitutes and Other Biomaterials report synopsis and brochure LYNCH Biologics LLC (LBIO) announced that it has closed on a transaction with Luitpold Pharmaceuticals Inc. (LPI), under which LBIO hasacquired all rights relating to GEM 21S Growth Factor Enhance Matrix, and certain additional assets related

iData ResearchLYNCH Biologics Closes on Transaction to Purchase GEM 21S® Growth Factor Enhanced Matrix for Dental Bone Regeneration
read more

OsteoTE Shows Promise for Bone Regeneration

No comments
OsteoTE Shows Promise for Bone Regeneration

Register to receive a free US Market Report Suite for Dental Bone Graft Substitutes and Other Biomaterials report synopsis and brochure PolarityTE™, Inc recently announced preclinical large animal model results for their new product, OsteoTE, which shows promise for bone regeneration. During the preclinical studies, the researchers found that OsteoTE not only recapitulated the cortical and cancellous

iData ResearchOsteoTE Shows Promise for Bone Regeneration
read more

CE Mark and Health Canada Regulatory Approvals for Datum Dental’s OSSIX Bone

No comments
CE Mark and Health Canada Regulatory Approvals for Datum Dental’s OSSIX Bone

Register to receive a free Europe Market Report Suite for Dental Bone Graft Substitutes and Other Biomaterials report synopsis and brochure Datum Dental, Ltd, leading provider of OSSIX® brand innovative solutions for bone and tissue regeneration for dentistry, proudly announces major regulatory clearances for OSSIX™ Bone with CE Mark in Europe and Health Canada approval. Powered by

iData ResearchCE Mark and Health Canada Regulatory Approvals for Datum Dental’s OSSIX Bone
read more

Geistlich Expands Bio-Gide® Portfolio

No comments
Geistlich Expands Bio-Gide® Portfolio

Register to receive a free US Market Report Suite for Dental Bone Graft Substitutes and Other Biomaterials report synopsis and brochure Geistlich Pharma North America, Inc., introduces Geistlich Bio-Gide® Compressed and Geistlich Bio-Gide® Shape to its portfolio of resorbable collagen membranes. Geistlich Bio-Gide® Compressed and Geistlich Bio-Gide® Shape were developed with the same biological properties and predictable results

iData ResearchGeistlich Expands Bio-Gide® Portfolio
read more

Orthogen, LLC Strives to Create Superior Dental Bone Graft Materials

No comments
Orthogen, LLC Strives to Create Superior Dental Bone Graft Materials

Register to receive a free US Market Report Suite for Dental Bone Graft Substitutes and Other Biomaterials report synopsis and brochure The acclaimed researchers and manufacturers of NanoGen and DentoGen—the specialists at Orthogen, LLC—strive to create superior dental bone grafting materials. With roots at New York University and operating as a division of BioLok International, Orthogen, LLC

iData ResearchOrthogen, LLC Strives to Create Superior Dental Bone Graft Materials
read more